NF-κB transcription factors: Critical regulators of hematopoiesis and neuronal survival

Cytokine and Growth Factor Reviews

Volumn 11, Issue 4, 2000, Pages 303-320

  Denk, Andrea ^a   Wirth, Thomas ^a   Baumann, Bernd ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

Apoptosis; Hematopoiesis; Neuronal survival; NF B; Signal transduction

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CELL SURVIVAL; HEMATOPOIESIS; HUMAN; IMMUNE RESPONSE; NERVE CELL; ANIMAL; B LYMPHOCYTE; CYTOLOGY; DENDRITIC CELL; GENETICS; MUTATION; NEUROLOGIC DISEASE; PHYSIOLOGY; REVIEW; T LYMPHOCYTE;

ANIMALS; APOPTOSIS; B-LYMPHOCYTES; CELL DIFFERENTIATION; CELL SURVIVAL; DENDRITIC CELLS; HEMATOPOIESIS; HUMANS; MUTATION; NERVOUS SYSTEM DISEASES; NEURONS; NF-KAPPA B; T-LYMPHOCYTES;

EID: 0033624450     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6101(00)00009-5     Document Type: Review

References (211)

1. The NF-κB and IκB proteins: New discoveries and insights
2. The NF-κB/Rel system of transcriptional activators
3. IκB proteins: Structure, function and regulation
4. How NF-kappaB is activated: The role of the IkappaB kinase (IKK) complex
5. Complementation cloning of NEMO, a component of the IκB kinase complex essential for NF-κB activation
6. Multiple nuclear factors interact with the immunoglobulin enhancer sequences
7. Inducibility of κ immunoglobulin enhancer-binding protein NF-κB by a posttranslational mechanism
8. Distinct NF-κB/Rel transcription factors are responsible for tissue-specific and inducible gene activation
9. NF-κB activity in transgenic mice: Developmental regulation and tissue specifity
10. Two distinct mechanisms contribute to the constitutive activation of RelB in lymphoid cells
11. Constitutive and inducible Rel/NF-κB activities in mouse thymus and spleen
12. Induction of nuclear NF-κB during primary B cell differentiation
13. Expression of relB transcripts during lymphoid organ development: Specific expression in dendritic antigen-presenting cells
14. Developmental expression of the mouse c-rel proto-oncogene in hematopoietic organs
15. Differential interactions of Rel-NF-κB complexes with IκBα determine pools of constitutive and inducible NF-κB activity
16. A role for nuclear NF-κB in B-cell-specific demethylafion of the Igκ locus
17. Enhanced degradation is responsible for constitutive NF-κB activity in mature murine B-cell lines
18. In vivo control of NF-κB activation by IκBα
19. Regulation of IkappaB beta in WEHI 231 mature B Cells
20. Activators and target genes of Rel/NF-kappaB transcription factors
21. Control of development and immunity by Rel transcription factors in Drosophila
22. Aberrant rel/nfkb genes and activity in human cancer
23. The v-rel oncogene promotes malignant T-cell leukemia/lymphoma in transgenic mice
24. B cells from p50/NF-kappa B knockout mice have selective defects in proliferation, differentiation, germ-line CH transcription, and Ig class switching
25. NF-kappa B RelA-deficient lymphocytes: Normal development of T cells and B cells, impaired production of IgA and IgG1 and reduced proliferafive responses
26. Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression
27. The p65 subunit of NF-kappa B is redundant with p50 during B cell proliferative responses, and is required for germline CH transcription and class switching to IgG3
28. Genetic approaches in mice to understand Rel/NF-kappaB and IkappaB function: Transgenics and knockouts
29. B lymphocytes differentially use the Rel and nuclear factor kappaB1 (NF-kappaB1) transcription factors to regulate cell cycle progression and apoptosis in quiescent and mitogen-activated cells
30. Rel/NF-κB transcription factors and the control of apoptosis
31. Control of apoptosis by Rel/NF-kappaB transcription factors
32. Inhibition of NF-kappaB/Rel induces apoptosis of murine B cells
33. C-Rel is essential for B lymphocyte survival and cell cycle progression
34. Inhibition of c-myc expression induces apoptosis of WEHI 231 murine B cells
35. Rel-dependent induction of A1 transcription is required to protect B cells from antigen receptor ligation-induced apoptosis
36. Overexpression of RelA causes G1 arrest and apoptosis in a pro-B cell line
37. The immunoglobulin class switch: Beyond 'Accessibility'
38. CD40 cross-linking induces Ig epsilon germline transcripts in B cells via activation of NF-kappaB: Synergy with IL-4 induction
39. Regulation of 3' IgH enhancers by a common set of factors, including kappa B-binding proteins
40. B cells genetically deficient in the c-Rel transactivation domain have selective defects in germline CH transcription and Ig class switching
41. Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses
42. Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-κB/Rel family
43. Failure of lymphopoiesis after adoptive transfer of NF-κB-deficient fetal liver cells
44. Nuclear factor (NF)-kappa B2 (p100/p52) is required for normal splenic microarchitecture and B cell-mediated immune responses
45. Mice deficient in nuclear factor (NF)-kappa B/p52 present with defects in humoral responses, germinal center reactions, and splenic microarchitecture
46. Critical roles for the Bcl-3 oncoprotein in T cell-mediated immunity, splenic microarchitecture, and germinal center reactions
47. p50-NF-kappaB complexes partially compensate for the absence of RelB: Severely increased pathology in p50(-/-)relB(-/-) double-knockout mice
48. Requirement for NF-κB in osteoclast and B-cell development
49. An intact NF-kappa B signaling pathway is required for maintenance of mature B cell subsets
50. B cell-specific demethylation: A novel role for the intronic κ chain enhancer sequence
51. Corepression of RelA and c-Rel inhibits, immunoglobulin κ gene transcription and rearrangement in precursor B lymphocytes
52. Coordinate transcription and V(D)J recombination of the kappa immunoglobulin lightchain locus: NF-kappaB-dependent and -independent pathways of activation
53. Molecular basis for developmental changes in interleukin-2 gene inducibility
54. Physiologic activation of T cells via the T cell receptor induces NF-kappa B
55. + T lymphocytes
56. Expression and induction of nuclear factor-κB-related proteins in thymocytes
57. Regulation of interleukin-2 gene enhancer activity by the T cell accessory molecule CD28
58. Regulation of the interleukin-2 CD28-responsive element by NF-ATp and various NF-kappaB/Rel transcription factors
59. Rel-deficient T cells exhibit defects in production of interleukin 3 and granulocyte-macrophage colony-stimulating factor
60. C-Rel is crucial for lymphocyte proliferation but dispensable for T cell effector function
61. Expression of relB is required for the development of thymic medulla and dendritic cells
62. Thymic cortical epithelium is sufficient for the development of mature T cells in relB-deficient mice
63. Unopposed positive selection and autoreactivity in mice expressing class II MHC only on thymic cortex
64. Both multiorgan inflammation and myeloid hyperplasia in RelB-deficient mice are T cell dependent
65. Transcription factors in mouse fetal thymus development
66. Expression of constitutively active IκBb in T cells of transgenic mice: Persistent NF-κB activity is required for T-cell immune responses
67. Perturbation of the T lymphocyte lineage in transgenic mice expressing a constitutive repressor of nuclear factor (NF)-κB
68. Abnormal T lymphocyte development induced by targeted overexpression of IkappaB alpha
69. In vivo inhibition of NF-kappa B in T-lineage cells leads to a dramatic decrease in cell proliferation and cytokine production and to increased cell apoptosis in response to mitogenic stimuli, but not to abnormal thymopoiesis
70. An essential role for nuclear factor kappaB in promoting double positive thymocyte apoptosis
71. Lineage-specific differences among CD8+ T cells in their dependence of NF-kappa B/Rel signaling
72. Activation-dependent transcriptional regulation of the human Fas promoter requires NF-kappaB p50-p65 recruitment
73. Regulation of Fas-dependent activation-induced T cell apoptosis by cAMP signaling: A potential role for transcription factor NF-kappa B
74. Apoptosisresistant T cells have a deficiency in NF-kappaB-mediated induction of Fas ligand transcription
75. Impaired fetal thymocyte development after efficient adenovirus-mediated inhibition of NF-κB activation
76. IkappaBepsilon-deficient mice: Reduction of one T cell precursor subspecies and enhanced Ig isotype switching and cytokine synthesis
77. Stimulation of thymocytes before and after positive selection results in the induction of different NF-kappa B/Rel protein complexes
78. The transcriptional regulator Rel is essential for antigen receptor-mediated stimulation of mature T cells but dispensable for positive and negative selection of thymocytes and T cell apoptosis
79. Nuclear factor kappaB is required for peptide antigen-induced differentiation of a CD4+ CD8+ thymocyte line
80. Survival-independent function of NF-kappaB/Rel during late stages of thymocyte differentiation
81. Mice lacking the transcription factor subunit Rel can clear an influenza infection and have functional anti-viral cytotoxic T cells but do not develop an optimal antibody response
82. Multifocal defects in immune responses in RelB-deficient mice
83. Regulation of NF-kappa B activation in T helper 1 and T helper 2 cells
84. Dendritic cell progenitor is transformed by a conditional v-Rel estrogen receptor fusion protein v-RelER
85. Differential expression of Rel/NF-kappaB and octamer factors is a hallmark of the generation and maturation of dendritic cells
86. Differential expression of the transcription factor NF-kappaB during human mononuclear phagocyte differentiation to macrophages and dendritic cells
87. Coexpression of NF-kappa B/Rel and Sp1 transcription factors in human immunodeficiency virus 1-induced, dendritic cell-T-cell syncytia
88. Nuclear localization of RelB is associated with effective antigen- presenting cell function
89. Dendritic cell survival and maturation are regulated by different signaling pathways
90. RelB is essential for the development of myeloid-related CD8alpha- dendritic cells but not of lymphoid-related CD8alpha + dendritic cells
91. Dendritic-like cells from relB mutant mice
92. A brain-specific transcription activator
93. NF-kappa B activates the HIV promoter in neurons
94. NF-kappa B-like factors in the murine brain. Developmentally-regulated and tissue-specific expression
95. Brain synapses contain inducible forms of the transcription factor NF-κB
96. Interleukin-1 activates transcription factor NF kappa B in glial cells
97. Transcription factor NF-kappa B is activated in microglia during experimental autoimmune encephalomyelitis
98. Kappa B enhancer-binding complexes that do not contain NF-kappa B are developmentally regulated in mammalian brain
99. Characterization of a neuronal kappaB-binding factor distinct from NF-kappaB
100. Identification and characterization of a κB/Rel binding site in the regulatory region of the amyloid precursor protein gene
101. Selective activation of NF-κB by nerve growth factor through the neurotrophin receptor p75
102. Synaptic activation of NF-kappa B by glutamate in cerebellar granule neurons in vitro
103. Constitutive NF-kappa B activity in neurons
104. Age-associated alterations in hippocampal and basal forebrain nuclear factor kappa B activity
105. NF-κB: A crucial transcription factor for glial and neuronal cell function
106. High levels of c-rel expression are associated with programmed cell death in the developing avian embryo and in bone marrow cells in vitro
107. Nuclear factor-kappa B contributes to excitotoxin-induced apoptosis in rat striatum
108. Kainic acid-induced apoptosis in rat striatum is associated with nuclear factor-kappaB activation
109. Nerve growth factor-dependent activation of NF-kappaB contributes to survival of sympathetic neurons
110. Stimulation of ionotropic glutamate receptors activates transcription factor NF-κB in primary neurons
111. Interleukin-1beta and glutamate activate the NF-kappaB/Rel binding site from the regulatory region of the amyloid precursor protein gene in primary neuronal cultures
112. Regulation of NF-kappa B activity in rat dorsal root ganglia and PC12 cells by tumour necrosis factor and nerve growth factor
113. Neuronal survival activity of s100betabeta is enhanced by calcineurin inhibitors and requires activation of NF-kappaB
114. A mu-receptor opioid agonist induces AP-1 and NF-kappa B transcription factor activity in primary cultures of rat cortical neurons
115. Non-enzymatically glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid beta-peptide
116. Hydrogen peroxide mediates amyloid beta protein toxicity
117. Induction of neuroprotective kappa B-dependent transcription by secreted forms of the Alzheimer's beta-amyloid precursor
118. NF-kappaB activity is induced by neural cell adhesion molecule binding to neurons and astrocytes
119. Tumor necrosis factors α and β protect neurons against amyloid beta-peptide toxicity: Evidence for involvement of a κB-binding factor and attenuation of peroxide and Ca2+ accumulation
120. Ceramide protects hippocampal neurons against excitotoxic and oxidative insults, and amyloid beta-peptide toxicity
121. NF-kappa B: A crucial transcription factor for glial and neuronal cell function
122. Glutamate-dependent activation of NF-κB during mouse cerebellum development
123. Expression of rat serum amyloid A1 gene involves both C/EBP-like and NF kappa B-like transcription factors
124. Cytokines, endotoxin, and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes
125. Thiol modulation of TNF alpha and IL-1 induced MnSOD gene expression and activation of NF-kappa B
126. Characterization and functional analysis of the promoter of RAGE, the receptor for advanced glycation end products
127. Brain injury and tumor necrosis factors induce calbindin D-28k in astrocytes: Evidence for a cytoprotective response
128. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB
129. p75-mediated NF-kappaB activation enhances the survival response of developing sensory neurons to nerve growth factor
130. Lack of the p50 subunit of nuclear factor-kappaB increases the vulnerability of hippocampal neurons to excitotoxic injury
131. NF-κB is activated and promotes cell death in focal cerebral ischemia
132. Transcription factor NF-kappaB is activated in primary neurons by amyloid beta peptides and in neurons surrounding early plaques from patients with Alzheimer disease
133. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease
134. Nuclear translocation of NF-kappaB in cholinergic neurons of patients with Alzheimer's disease
135. Enhancement of immunoreactivity for NF-kappa B in the hippocampal formation and cerebral cortex of Alzheimer's disease
136. Inhibition of NF-kappaB potentiates amyloid beta-mediated neuronal apoptosis
137. Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with Parkinson disease
138. C-Jun, JNK/SAPK kinases and transcription factor NF-kappa B are selectively activated in astrocytes, but not motor neurons, in amyotrophic lateral sclerosis
139. Activation of nuclear factor kappa B in brains from children with HIV-1 encephalitis
140. Stimulation of HIV type 1 gene expression and induction of NF-kappa B (p50/p65)-binding activity in tumor necrosis factor alpha-treated human fetal glial cells
141. Correction of radiation sensitivity in Ataxia Telangiectasia cells by a truncated IκB-α
142. Degeneration of neurons, synapses, and neuropil and glial activation in a murine Atm knockout model of ataxia-telangiectasia
143. Alteration of transcription factor binding activities in the ischemic rat brain
144. Global ischemia activates nuclear factor-kappa B in forebrain neurons of rats
145. Drug-induced neuroprotection from global ischemia is associated with prevention of persistent but not transient activation of nuclear factor- kappaB in rats
146. Increased cortical nuclear factor-κB (NF-κB) DNA binding activity after traumatic brain injury in rats
147. Traumatic spinal cord injury induces nuclear factor-kappaB activation
148. Inhibition of NFκB DNA binding activity by glucocorticoids in rat brain
149. Seizure activity results in a rapid induction of nuclear factor-kappa B in adult but not juvenile rat limbic structures
150. Roles of nuclear factor kappaB in neuronal survival and plasticity
151. Tumor necrosis factors protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis
152. Activation of NF-kappaB protects hippocampal neurons against Oxidative stressinduced apoptosis: Evidence for induction of manganese superoxide dismutase and suppression of peroxynitrite production and protein tyrosine nitration
153. Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors
154. Mitochondrial manganese superoxide dismutase prevents neural apoptosis and reduces ischemic brain injury: Suppression of peroxynitrite production, lipid peroxidation, and mitochondrial dysfunction
155. Exacerbation of damage and altered NF-kappaB activation in mice lacking tumor necrosis factor receptors after traumatic brain injury
156. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells
157. bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes
158. Tumor necrosis factor induces Bcl-2 and Bcl-x expression through NFkappaB activation in primary hippocampal neurons
159. Inactivation of bcl-2 results in progressive degeneration of motoneurons, sympathetic and sensory neurons during early postnatal development
160. Bcl-2 is required for cranial sensory neuron survival at defined stages of embryonic development
161. Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice
162. Overexpression of BCL-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia
163. Bcl-2 transgene expression can protect neurons against developmental and induced cell death
164. Increased cerebellar Purkinje cell numbers in mice overexpressing a human bcl-2 transgene
165. Bcl-xL is an antiapoptotic regulator for postnatal CNS neurons
166. Bcl-Xshort is elevated following severe global ischemia in rat brains
167. Neuroprotection by aspirin and sodium salicylate through blockade of NF-kappaB activation
168. Inhibition of the activity of a neuronal kappaB-binding factor by glutamate
169. Nuclear factor kappaB nuclear translocation upregulates c-Myc and p53 expression during NMDA receptor-mediated apoptosis in rat striatum
170. Intrastriatal dopamine injection induces apoptosis through oxidation - Involved activation of transcription factors AP-1 and NF-kappaB in rats
171. Free radical scavenger OPC-14117 attenuates quinolinic acid-induced NF-kappaB activation and apoptosis in rat striatum
172. p53 expression in brain after middle cerebral artery occlusion in the rat
173. p53-immunoreactive protein and p53 mRNA expression after transient middle cerebral artery occlusion in rats
174. p53 induction is associated with neuronal damage in the central nervous system
175. Attenuation of p53 expression protects against focal ischemic damage in transgenic mice
176. Loss of the p53 tumor suppressor gene protects neurons from kainate-induced cell death
177. Evidence for p53-mediated modulation of neuronal viability
178. NF-kappa B activation of p53. A potential mechanism for suppressing cell growth in response to stress
179. Induction of tumour-suppressor phosphoprotein p53 in the apoptosis of cultured rat cerebellar neurones triggered by excitatory amino acids
180. Possible role of NF-kappaB and p53 in the glutamate-induced pro- apoptotic neuronal pathway
181. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo
182. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
183. Bax-deficient mice with lymphoid hyperplasia and male germ cell death
184. BAX is required for neuronal death after trophic factor deprivation and during development
185. Bax involvement in p53-mediated neuronal cell death
186. Differential regulation of Bax, Bcl-2, and Bcl-X proteins in focal cortical ischemia in the rat
187. Evidence for apoptotic cell death in the choroid plexus following focal cerebral ischemia
188. Upregulation of bax protein levels in neurons following cerebral ischemia
189. NF-kappaB-mediated upregulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes
190. DNA damaging agents induce expression of Fas ligand and Subsequent apoptosis in T lymphocytes via the activation of NF-kappa B and AP-1
191. CD95 ligand (Fas-L/ APO-1L) and tumor necrosis factor-related apoptosis-inducing ligand mediate ischemia-induced apoptosis in neurons
192. Structure and regulation of the human interferon regulatory factor I (IRF-1) and IRF-2 genes: Implications for a gene network in the interferon system
193. The transcription factor interferon regulatory factor 1 is expressed after cerebral ischemia and contributes to ischemic brain injury
194. Requirement for transcription factor IRF-1 in NO synthase induction in macrophages
195. Role of interferon regulatory factor I in induction of nitric oxide synthase
196. The NF-kappaB/Rel family of proteins mediates Abeta-induced neurotoxicity and glial activation
197. Secreted beta-amyloid precursor protein counteracts the proapoptotic action of mutant presenilin-1 by activation of NF-kappaB and stabilization of calcium homeostasis
198. Inhibition of nuclear factor kappa B (NFkappaB) activity induces nerve growth factor-resistant apoptosis in PC12 cells
199. NGF-resistant PC12 cell death induced by arachidonic acid is accompanied by a decrease of active PKC zeta and nuclear factor kappa B
200. High constitutive NF-kappaB activity mediates resistance to oxidative stress in neuronal cells
201. Photooxidative stress down-modulates the activity of nuclear factor-kappaB via involvement of caspase-1, leading to apoptosis of photoreceptor cells
202. Insulin-like growth factor-1-mediated neuroprotection against oxidative stress is associated with activation of nuclear factor kappaB
203. Central nervous system DNA fragmentation induced by the inhibition of nuclear factor kappa B
204. Loss of NF-kappaB activity during cerebral ischemia and TNF cytotoxicity
205. Oxidized lipoproreins activate NF-kappaB binding activity and apoptosis in PC12 cells
206. Activation of AP-1 and nuclear factor-kappaB transcription factors is involved in hydrogen peroxide-induced apoptotic cell death of oligodendrocytes
207. Global cerebral ischemia activates nuclear factor-kappa B prior to evidence of DNA fragmentation
208. Nuclear factor-kappa B activation during cerebral reperfusion: Effect of attenuation with N-acetylcysteine treatment
209. Neuroprotection achieved with a novel proteasome inhibitor which blocks NF-kappaB activation
210. Induction of NF-kappaB activity during haloperidol-induced oxidative toxicity in clonal hippocampal cells: Suppression of NF-kappaB and neuroprotection by antioxidants
211. Activation of NF-kappaB by reactive oxygen intermediates in the nervous system